Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2
On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…
-
-
MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorine
On Jun. 7, 2021, MediciNova announced it had initiated a sheep study to investigate MN-166 (ibudilast) in an…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA granted accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment
On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
-
Moderna applied for EU coronavirus vaccine authorization covering teens
On Jun. 7, 2021, Moderna announced announced that it had submitted for a variation to the conditional marketing…
-
Moderna and Medison Pharma partnered to commercialize COVID-19 vaccine in Central Eastern Europe and Israel
On Jun. 7, 2021, Moderna announced a new agreement to commercialize its COVID-19 Vaccine across Central Eastern Europe…
-
OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription use
On Jun. 7, 2021, OraSure Technologies announced that it had received Emergency Use Authorization (EUA) from the U.S….
-
FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients
On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…
-
Chimerix received U.S. FDA approval for TEMBEXA (brincidofovir) for treatment of smallpox
On Jun. 4, 2021, The U.S. Food and Drug Administration (FDA) approved Chimerix’s Tembexa (brincidofovir) tablets and oral…
-
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration (FDA) announced it had approved Novo Nordisk’s Wegovy…
-
Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and Canada
On Jun. 3, 2021, Resverlogix announced a partnership to support planned commercialization of apabetalone in the United States…
-
NIH researchers identified potential new antiviral drug for COVID-19
On Jun. 3, 2021, the National Institutes of Health (NIH) announced that the experimental drug TEMPOL may be…
-
Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19
On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…
-
Moderna announced agreement to supply the Republic of Botswana with COVID-19 vaccine
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
-
Lonza and Moderna announced collaboration for drug substance manufacturing of COVID-19 Vaccine in the Netherlands
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
-
UNICEF and Moderna announced long term agreement to supply vaccine on behalf of the COVAX facility
On Jun. 2, 2021, UNICEF announced it had signed a long-term agreement with Moderna for the supply of COVID-19 vaccine on behalf of the…
-
Vaxxas and collaborators revealed potential of Vaxxas’ high-density microarray patch to deliver SARS-CoV-2 vaccine
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxas’ novel high-density microarray patch (HD-MAP)…
-
Scientists discovered a new genetic form of ALS in children
On Jun. 1, 2021, in a study of 11 medical-mystery patients, an international team of researchers led by…
-
NIH launched clinical trial of universal influenza vaccine candidate
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
-
Sanofi and Parkinson’s Foundation collaborated to advance availability of free genetic testing and counseling for people with Parkinson’s disease
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
-
U.S. blood donations declared safe under current COVID-19 screening guidelines
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
-
WHO validated Sinovac COVID-19 vaccine for emergency use
On Jun. 1, 2021, World Health Organization (WHO) validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine | WHO
WHO $50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery
On Jun. 1, 2021, the heads of the world’s predominant global financing, health and trade agencies united to…
-
Moderna announced rolling submission of Biologics License Application with FDA for COVID-19 vaccine
On Jun. 1, 2021, Moderna announced that it had initiated the rolling submission process with the U.S. Food…
-
CytoDyn received first order from Chiral Pharma for use of Leronlimab for COVID-19 patients in the Philippines
On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for…
-
HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…
-
NIH clinical trial evaluating mixed COVID-19 vaccine schedules began
On Jun. 1, 2021, the National Institutes of Health (NIH) announced that it had started a Phase 1/2…
-
AquaBounty received approval for the sale of GE Atlantic Salmon in Brazil
On Jun. 1, 2021, AquaBounty Technologies announced the successful completion of the first commercial scale harvest of its…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics
FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
-
Omeros announced preliminary results from additional critically Ill COVID-19 patients treated with narsoplimab
Omeros announced preliminary results from the second cohort of critically ill COVID-19 patients treated with narsoplimab in Bergamo,…
-
Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
